Search Results - Sarkis, Omar

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma

    The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma by Ghayad, Sandra E., Rammal, Ghina, Sarkis, Omar, Basma, Hussein, Ghamloush, Farah, Fahs, Assil, Karam, Mia, Harajli, Mohamad, Rabeh, Wissam, Mouawad, Joe E., Zalzali, Hassan, Saab, Raya

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma

    Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma by Al-Tahan, Alaa, Sarkis, Omar, Harajly, Mohamad, Baghdadi, Omar Kebbe, Zibara, Kazem, Boulos, Fouad, Dighe, Dipti, Kregel, Steven, Bazarbachi, Ali, El-Sabban, Marwan, Skapek, Stephen X., Saab, Raya

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Split-dose menthol-enhanced PEG vs PEG-ascorbic acid for colonoscopy preparation

    Split-dose menthol-enhanced PEG vs PEG-ascorbic acid for colonoscopy preparation by Sharara, Ala I, Harb, Ali H, Sarkis, Fayez S, Chalhoub, Jean M, Badreddine, Rami, Mourad, Fadi H, Othman, Mahmoud, Masri, Omar

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables

    Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables by Didier, Romain, MD, Gaglia, Michael A., MD, MSc, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Negi, Smita I., MD, Omar, Al Fazir, MD, Gai, Jiaxing, MSPH, Torguson, Rebecca, MPH, Pichard, Augusto D., MD, Waksman, Ron, MD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Efficacy and Safety with Extended Follow-up in a Phase 1 Study of BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Heavily Pretreated Relapsed/Refractory (RR) Multiple Myeloma (MM)

    Efficacy and Safety with Extended Follow-up in a Phase 1 Study of BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patient... by Bal, Susan, Anderson, Larry D, Nadeem, Omar, Berdeja, Jesús G., Rossi, Adriana, Gregory, Tara, Koçoğlu, Mehmet Hakan, Martin, Thomas G, Egan, Daniel N., Costa, Luciano J., Hu, Hongxiang, Chen, Jinjie, Mei, Chaoqun, Sarkis, Naomey, Shrestha, Alok, Ziyad, Safiyyah, Kao, Wei-Ming, Kaeding, Allison J, Burgess, Michael R., Htut, Myo

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1-3 Prior Regimens: Updated Phase 1 Safety and Efficacy Results

    BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1-... by Bal, Susan, Htut, Myo, Berdeja, Jesús G., Anderson, Larry D, Rossi, Adriana, Gregory, Tara, Martin, Thomas G, Costa, Luciano J., Hu, Hongxiang, Chen, Jinjie, Mei, Chaoqun, Sarkis, Naomey, Shrestha, Alok, Ziyad, Safiyyah, Kao, Wei-Ming, Kaeding, Allison J, Burgess, Michael R., Nadeem, Omar

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study

    BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myelo... by Bal, Susan, Htut, Myo, Nadeem, Omar, Anderson, Larry D., Koçoğlu, Hakan, Gregory, Tara, Rossi, Adriana C, Martin, Tom, Egan, Daniel N., Costa, Luciano, Hu, Hongxiang, Chen, Yanping, Li, Shaoyi, Kelly, Lisa M., Sarkis, Naomey, Ziyad, Safiyyah, Kao, Wei-Ming, Kaeding, Allison June, Burgess, Michael R., Berdeja, Jésus G

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: